Related Experiment Video
Updated: May 1, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
The Randomised Clinical Trial and the Hazard Ratio - medical research's Emperor's New Clothes?
Richard Stephens1, David Stewart
1Retired, previously MRC Clinical Trials Unit, London, UK. richardjamesstephens@gmail.com.
Abstract:
As the enthusiasm for individualized treatment and targeted therapies continues to gain momentum, it seems timely to re-assess whether our current research tools are fit for purpose. Randomized Clinical Trials compare groups of patients, the Hazard Ratio is a 'group summary statistic', and modeling shows that the same Hazard Ratio score could result from a number of scenarios. Thus the current tools do not provide definitive information as to how to treat an individual patient. We therefore need to concentrate on the use of predictive factor analyses to identify the characteristics of subgroups of patients who respond to specific treatments.
Related Concept Videos
Hazard Ratio
For example, in a clinical trial...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blinding
Comparing the Survival Analysis of Two or More Groups
Relative Risk
Odds Ratio

